Vimarsana
Biggest News Aggregation in the World

Celia Ning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celia Ning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celia Ning Today - Breaking & Trending Today

Two MNCs and one local giant get HMO approvals from China authorities - Vimarsana News

Two MNCs and one local giant get HMO approvals from China authorities

Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local diary giant Mengniu, announcing that they have received approvals in the past week.

Healthier Choices: Nutri V upcycled snacks, Junlebao probiotic yoghurt, better-for-you rice noodle innovation and more - Vimarsana News

Healthier Choices: Nutri V upcycled snacks, Junlebao probiotic yoghurt, better-for-you rice noodle innovation and more

Nutri V upcycled snacks, Junlebao probiotic yoghurt, better-for-you rice noodle innovation and more feature in this edition of Healthier Choices.

Junlebao launches yogurt containing 10 probiotic strains - Vimarsana News

Junlebao launches yogurt containing 10 probiotic strains

China dairy firm Junlebao launches a new yogurt containing 10 probiotic strains, including the firm’s patented strain and others derived from kefir.

Junlebao launches yogurt containing 10 probiotic strains - Vimarsana News

Junlebao launches yogurt containing 10 probiotic strains

China dairy firm Junlebao launches a new yogurt containing 10 probiotic strains, including the firm’s patented strain and others derived from kefir.

Only major local brands and MNCs to thrive in China's tougher infant formula market – experts - Vimarsana News

Only major local brands and MNCs to thrive in China's tougher infant formula market – experts

It will mostly be the major domestic players and MNCs that will thrive in China’s infant formula market in the upcoming years, claim experts, citing a raft of reasons such as a more stringent regulatory environment, negative population growth, and an under-performing economy as hurdles for other firms.